
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Active composition
+2 more active ingredients
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.
Medical applications
Novomet-Trio 2 Tablet SR is a triple-combination antidiabetic medication, featuring Glimepiride (2mg), Metformin (500mg), and Voglibose (0.2mg). This pharmaceutical formulation is designed to improve glycemic control in type 2 diabetes mellitus patients. Glimepiride, a sulfonylurea, stimulates insulin secretion, while Metformin, a biguanide, reduces hepatic glucose production and improves insulin sensitivity. Voglibose, an alpha-glucosidase inhibitor, delays carbohydrate absorption in the gut. This synergistic action aims to achieve optimal blood glucose management and ensure patient safety and efficacy. Always consult a healthcare professional for proper dosage and administration guidelines.
How to use Novomet-Trio Tablet SR Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Novomet-Trio 2 Tablet SR is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Novomet-Trio 2 Tablet SR.
High Risk
Novomet-Trio 2 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Novomet-Trio 2 Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Novomet-Trio 2 Tablet SR may be needed. Please consult your doctor. Novomet-Trio 2 Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Regular Checkup
Novomet-Trio 2 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Novomet-Trio 2 Tablet SR is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Novomet-Trio 2 Tablet SR is, however, not recommended in patients with severe kidney disease.
Regular Checkup
0 reviews for Novomet-Trio 2 Tablet SR

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+2 more active ingredients
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.
Medical applications
Novomet-Trio 2 Tablet SR is a triple-combination antidiabetic medication, featuring Glimepiride (2mg), Metformin (500mg), and Voglibose (0.2mg). This pharmaceutical formulation is designed to improve glycemic control in type 2 diabetes mellitus patients. Glimepiride, a sulfonylurea, stimulates insulin secretion, while Metformin, a biguanide, reduces hepatic glucose production and improves insulin sensitivity. Voglibose, an alpha-glucosidase inhibitor, delays carbohydrate absorption in the gut. This synergistic action aims to achieve optimal blood glucose management and ensure patient safety and efficacy. Always consult a healthcare professional for proper dosage and administration guidelines.
How to use Novomet-Trio Tablet SR Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Novomet-Trio 2 Tablet SR is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Novomet-Trio 2 Tablet SR.
High Risk
Novomet-Trio 2 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Novomet-Trio 2 Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Novomet-Trio 2 Tablet SR may be needed. Please consult your doctor. Novomet-Trio 2 Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Regular Checkup
Novomet-Trio 2 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Novomet-Trio 2 Tablet SR is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Novomet-Trio 2 Tablet SR is, however, not recommended in patients with severe kidney disease.
Regular Checkup
0 reviews for Novomet-Trio 2 Tablet SR













